Agilent Technologies, Inc. (A) est une société cotée en bourse dans le Santé secteur, opérant dans le Medical - Diagnostics & Research secteur d'activité. Le siège social de l'entreprise est situé à Santa Clara, CA, United States. Le PDG actuel est Padraig McDonnell.
A a date d'introduction en bourse 1999-11-18, 17,900 employés à temps plein, cotée sur le NYSE, une capitalisation boursière de $34.05B.
Agilent Technologies, Inc. is a global provider of analytical instruments, software, and services serving the life sciences, diagnostics, and applied chemical markets. The company operates through three primary segments: Life Sciences and Applied Markets, which offers chromatography and mass spectrometry systems, spectroscopy instruments, and cell analysis technologies; Diagnostics and Genomics, which provides genomic arrays, next-generation sequencing solutions, and diagnostic reagents; and Agilent CrossLab, which supplies consumables, columns, and comprehensive laboratory support services. Agilent's products enable customers to accelerate innovation and solve critical challenges in drug discovery, clinical diagnostics, food safety, and environmental testing. The company distributes its solutions worldwide through direct sales, distributors, resellers, and digital channels.
